A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W

Chr. Hansen

Company-logo  COMPANY DETAILS
Chr. Hansen
10-12 Bøge Allé
Hørsholm
DK-2970
Denmark

Website
Mail
Call
  +45 45 74 74 74


Printer
  +45 45 74 88 88

HEALTH CATEGORIES

digestive health


Facebook   
Google   
Linkedin   
Twitter   
Youtube   

Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.



Articles On NutritionInsight
FormattedPicture

NUTRITION & HEALTH NEWS

Future-proof campus: Chr. Hansen to give facilities a sustainable overhaul

30 Aug 2019 --- Chr. Hansen is giving its Danish campus a modern and “future-proof” makeover in response to the increasing demand for natural and sustainable products. This will help... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

BacThera: Chr. Hansen and Lonza US$99m joint venture receives name and approvals

29 Aug 2019 --- BacThera is the newly dubbed 50/50 joint venture (JV) from global bioscience company Chr. Hansen and pharma contract manufacturing company Lonza. The new collaboration, which will... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Chr. Hansen: Strain-specific probiotic use can boost immune health, save billions in sick days, finds study

28 Aug 2019 --- Over two million antibiotic courses could be avoided each year if the US population took probiotics, according to a Chr. Hansen-sponsored study published in Frontiers in... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Advancing microbiome therapeutics: Vedanta Biosciences raises US$45.5m in funding

14 May 2019 --- Microbiome startup Vedanta Biosciences – developers of a new category of therapies for immune-mediated diseases using live human microbiome-derived bacteria – has raised... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Patent-pending probiotic mix dissolves harmful biofilms, may curb development of Crohn’s disease

04 Apr 2019 --- A patent-pending probiotic mix may help shield patients who suffer from gastrointestinal (GI) diseases from harmful biofilms – antibiotic-resistant microbial communities. This... Read More




Video Interviews
FormattedPicture

Probiotic Oil Drops for Infants and Young Children

31 May 2013 --- Chr. Hansen has launched a new probiotic product which has the potential to improve the gut and immune health of infants and young children: probiotic drops containing Chr. Hansen’s bacteria strain BB-12 and sunflower oil.

FormattedPicture

Taking Probiotics to Juice Applications

12 Jan 2012 --- Marie Brenoe of Chr. Hansen on Taking Probiotics to Juice Applications.




Articles On The World of Food Ingredients
FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Chr. Hansen Partners on Tomorrow’s Cultures

01 Feb 2016 --- Danish-headquartered Chr. Hansen has reported a strong start to the 2015/2016 financial year. An interview with Sten Estrup, VP at Chr. Hansen who talks about how new partnerships are indicative of how the company is investing in the future.

FormattedPicture

THE WORLD OF FOOD INGREDIENTS

Opinion Edge: How to Ride the Next Dairy Trend

30 Nov 2014 --- Key suppliers offer their thoughts on the key dairy trends. How can manufacturers benefit from the mainstreaming of the sports nutrition sector? How can the boom in protein and the needs of the aging global population be addressed?

FormattedPicture

THE WORLD OF FOOD INGREDIENTS

View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen

01 Mar 2013 --- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”




A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
Q
R
S
T
U
V
W